Renovion, Inc.

Quick facts

Phase 3 pipeline

• ARINA-1 · Respiratory
  ARINA-1 is a small molecule inhaled cystic fibrosis transmembrane conductance regulator (CFTR) corrector.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Renovion, Inc. portfolio CI brief
• Renovion, Inc. pipeline updates RSS